Skip to main content


Health

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.
557 of 1540




Newsletter Sign Up

Daily Readings

Reading 1, Ezekiel 36:23-28
I am going to display the holiness of my great name, which has ... Read More

Psalm, Psalms 51:12-13, 14-15, 18-19
Give me back the joy of your salvation, sustain in me a ... Read More

Gospel, Matthew 22:1-14
Jesus began to speak to them in parables once again, 'The ... Read More

Saint of the Day

August 21 Saint of the Day

St. Pius X
August 21: On June 2, 1835, Giuseppe Melchiorre Sarto saw the light of ... Read More